Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up

Condition(s) studied

Investigational drug(s) / intervention(s)

MobileLink: Patients who receive a MobileLink hip prosthesis system will be followed-up for 10 years.

Study summary

The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results.

The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.

Eligibility

Primary outcome measure(s)

• Survival rate of the complete MobileLink hip prosthesis system with revision for any reason as the endpoint, — 10-years
  calculated with Kaplan-Meier method.

Trial sites (2)

Other trials for the same condition